These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9838466)

  • 41. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
    Joya-Vazquez PP; Dodson FS; Dvorchik I; Gray E; Chesky A; Demetris AJ; Shakil O; Fung JJ; Vargas HE
    Transplantation; 2002 May; 73(10):1598-602. PubMed ID: 12042646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis].
    Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L
    Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
    Samuel D; Feray C; Bismuth H
    Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
    Marzano A; Gaia S; Ghisetti V; Carenzi S; Premoli A; Debernardi-Venon W; Alessandria C; Franchello A; Salizzoni M; Rizzetto M
    Liver Transpl; 2005 Apr; 11(4):402-9. PubMed ID: 15776431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
    Gao YJ; Zhang M; Jin B; Meng FP; Ma XM; Liu ZW; Su HB; Zhao JM; Li HW
    J Gastroenterol Hepatol; 2014 Mar; 29(3):554-60. PubMed ID: 24117714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case studies in orthotopic liver transplantation for hepatitis B: a panel discussion.
    Teperman L
    Clin Transplant; 2000; 14 Suppl 2():44-50. PubMed ID: 10965964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.
    Roche B; Feray C; Gigou M; Roque-Afonso AM; Arulnaden JL; Delvart V; Dussaix E; Guettier C; Bismuth H; Samuel D
    Hepatology; 2003 Jul; 38(1):86-95. PubMed ID: 12829990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver transplantation in HBsAg+ patients with postoperative immunoprophylaxis.
    Langrehr JM; Guckelberger O; Neumann U; Berg T; Schrem H; Kratschmer B; Knoop M; Steinmüller T; Lemmens HP; Keck H; Bechstein WO; Neuhaus R; Hopf U; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2841-2. PubMed ID: 9365584
    [No Abstract]   [Full Text] [Related]  

  • 52. Hepatitis B and liver transplantation. Problems and promises.
    Perrillo RP; Mason AL
    N Engl J Med; 1993 Dec; 329(25):1885-7. PubMed ID: 8247043
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience.
    Akcam AT; Ulku A; Rencuzogullari A; Eray IC; Okoh A; Kuran S; Dalcı K; Yalav O; Parsak CK; Sakman G; Demiryurek H
    Transplant Proc; 2015 Jun; 47(5):1445-9. PubMed ID: 26093739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.
    Ku W; Wang U; Nguyen MH
    Expert Opin Biol Ther; 2015 May; 15(5):665-77. PubMed ID: 25865452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
    Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Giakoustidis D; Giouleme O; Papanikolaou V; Akriviadis E; Vasiliadis T
    Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Liver transplantation in HBsAg-positive patients: does preventive immune treatment improve prognosis?].
    Erhard J; Layer P
    Z Gastroenterol; 1993 Apr; 31(4):267-8. PubMed ID: 8493809
    [No Abstract]   [Full Text] [Related]  

  • 57. Liver transplantation and management of the hepatitis B virus. Preface.
    Rizzetto M
    Dig Liver Dis; 2009 May; 41 Suppl 2():S183. PubMed ID: 19482254
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevention and treatment of HBV reinfection following liver transplantation].
    Yuan G; Duan Y; Wang F; Liang S; Zhu L
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):14-6. PubMed ID: 11856491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recurrence of virus B hepatitis after liver transplantation].
    Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
    Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between risk of hepatitis B virus recurrence and tissue expression of covalently closed circular DNA in living donor liver transplant recipients treated with high-dose hepatitis B immunoglobulin.
    Song GW; Ahn CS; Lee SG; Hwang S; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Kim N
    Transplant Proc; 2014 Dec; 46(10):3548-53. PubMed ID: 25498087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.